Published in J Gen Intern Med on January 01, 2003
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int (2004) 2.62
The osteoporosis care gap in Canada. BMC Musculoskelet Disord (2004) 1.81
Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int (2008) 1.34
Osteoporotic fractures and hospitalization risk in chronic spinal cord injury. Osteoporos Int (2008) 1.27
Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int (2009) 1.12
A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int (2006) 1.07
Characteristics of elderly patients admitted to an urban tertiary care hospital with osteoporotic fractures: correlations with risk factors, fracture type, gender and ethnicity. Osteoporos Int (2005) 0.98
Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. BMC Musculoskelet Disord (2005) 0.93
Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem. Osteoporos Int (2006) 0.93
Multinational survey of osteoporotic fracture management. Osteoporos Int (2004) 0.91
The importance of communication in secondary fragility fracture treatment and prevention. Osteoporos Int (2006) 0.90
Maximising functional recovery following hip fracture in frail seniors. Best Pract Res Clin Rheumatol (2013) 0.90
Correlates of use of antifracture therapy in older women with low bone mineral density. J Gen Intern Med (2006) 0.88
Barriers to effective management of osteoporosis in moderate and minimal trauma fractures: a prospective study. Osteoporos Int (2004) 0.82
Accident or osteoporosis?: Survey of community follow-up after low-trauma fracture. Can Fam Physician (2011) 0.80
Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study. BMC Womens Health (2013) 0.80
The effect of a fracture protocol on hospital prescriptions after minimal trauma fractured neck of the femur: a retrospective audit. Osteoporos Int (2005) 0.79
Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage. Clin Interv Aging (2015) 0.78
Knowledge of orthopaedic surgeons in managing patients with fragility fracture. Int Orthop (2012) 0.78
Barriers to postfracture osteoporosis care in postmenopausal women. J Gen Intern Med (2003) 0.75
The management of osteoporosis following hip fracture: how to improve our care. Osteoporos Int (2004) 0.75
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74
Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am (2000) 3.37
Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1999) 3.08
The crippling consequences of fractures and their impact on quality of life. Am J Med (1997) 2.98
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11
Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc (2002) 1.99
Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care (1998) 1.71
Costs and health effects of osteoporotic fractures. Bone (1994) 1.52
The economic and human costs of osteoporotic fracture. Am J Med (1995) 1.44
Osteoporosis intervention following distal forearm fractures: a missed opportunity? Arch Intern Med (2002) 1.36
Evaluation and treatment of postmenopausal osteoporosis. Semin Arthritis Rheum (1998) 1.32
Missed opportunities for prevention of osteoporotic fracture. Arch Intern Med (2002) 1.16
Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res (1996) 1.01
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc (2006) 5.32
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res (2004) 3.66
Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res (2004) 3.37
Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res (2004) 1.76
Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Obstet Gynecol (2004) 1.68
Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev (2009) 1.61
Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res (2002) 1.58
An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med (2004) 1.48
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II. Value Health (2009) 1.43
Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan. PLoS One (2013) 1.21
Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications. Cancer (2008) 1.16
Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer. Lung Cancer (2006) 1.05
Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin (2005) 0.99
Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis. Curr Med Res Opin (2006) 0.96
Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial. Med Care (2005) 0.95
Shifts in microbial community composition and function in the acidification of a lead/zinc mine tailings. Environ Microbiol (2013) 0.95
Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. Menopause (2003) 0.95
Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan. J Thorac Oncol (2010) 0.94
Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med (2007) 0.94
ACSL3 and GSK-3β are essential for lipid upregulation induced by endoplasmic reticulum stress in liver cells. J Cell Biochem (2011) 0.92
Interactive voice response telephone calls to enhance bone mineral density testing. Am J Manag Care (2006) 0.85
Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention Study. Headache (2010) 0.85
Management of osteoporosis in women aged 50 and older with osteoporosis-related fractures in a managed care population. Dis Manag (2003) 0.84
Evaluation of decision rules to identify postmenopausal women for intervention related to osteoporosis. Dis Manag (2003) 0.83
Vaccinia H1-related phosphatase is a phosphatase of ErbB receptors and is down-regulated in non-small cell lung cancer. J Biol Chem (2011) 0.82
Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants. Biochim Biophys Acta (2005) 0.82
Can migraineurs accurately identify their headaches as "migraine" at attack onset? Headache (2007) 0.81
Triptan use as a function of cardiovascular risk. A population-based study. Headache (2009) 0.81
Correlation of anaplastic lymphoma kinase overexpression and the EML4-ALK fusion gene in non-small cell lung cancer by immunohistochemical study. Chang Gung Med J (2012) 0.80
Predictability of future attacks by migraineurs: a prospective observational study. Headache (2010) 0.79
Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases. Cephalalgia (2012) 0.78
Single-trial EEG-based emotion recognition using kernel Eigen-emotion pattern and adaptive support vector machine. Conf Proc IEEE Eng Med Biol Soc (2013) 0.78
Triptan persistency among newly initiated users in a pharmacy claims database. Cephalalgia (2010) 0.78
Acute migraine treatment with oral triptans and NSAIDs in a managed care population. Headache (2008) 0.77
Patterns of atypical antipsychotic therapy use in adults with bipolar I disorder in the USA. Hum Psychopharmacol (2013) 0.77
Motor imagery vs. object-based visual imagery in adolescents with Autism Spectrum Disorder. J Vis (2015) 0.75
A novel hybrid metal-organic framework-polymeric monolith for solid-phase microextraction. Chemistry (2014) 0.75
Determination of trace amount of Cu2+ with a multi-responsive colorimetric and reversible chemosensor. Analyst (2013) 0.75
Lipase-supported metal-organic framework bioreactor catalyzes warfarin synthesis. Chemistry (2014) 0.75